(2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide

C170H184F6N30O6 — CID 167575913

IUPAC(2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide
SMILESCCCCCCc1ccc([C@@H](NCCc2ccc(C)cc2)C(=O)Nc2ccc(-c3cnn(C)c3)cn2)cc1.CCCCCCc1ccc([C@H](NCCc2ccc(C)cc2)C(=O)Nc2ccc(-c3cnn(C)c3)cn2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2cc(-c3cnn(C)c3)ccn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccc(C(F)(F)F)cc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2cc(-c3cnn(C)c3)ccn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccc(C(F)(F)F)cc2)cc1
InChIInChI=1S/2C32H39N5O.2C27H26F3N5O.2C26H27N5O/c2*1-4-5-6-7-8-25-13-15-27(16-14-25)31(33-20-19-26-11-9-24(2)10-12-26)32(38)36-30-18-17-28(21-34-30)29-22-35-37(3)23-29;2*1-18-3-5-19(6-4-18)13-14-31-25(20-7-10-23(11-8-20)27(28,29)30)26(36)34-24-12-9-21(15-32-24)22-16-33-35(2)17-22;2*1-19-8-10-20(11-9-19)12-14-28-25(21-6-4-3-5-7-21)26(32)30-24-16-22(13-15-27-24)23-17-29-31(2)18-23/h2*9-18,21-23,31,33H,4-8,19-20H2,1-3H3,(H,34,36,38);2*3-12,15-17,25,31H,13-14H2,1-2H3,(H,32,34,36);2*3-11,13,15-18,25,28H,12,14H2,1-2H3,(H,27,30,32)/t2*31-;4*25-/m101010/s1
InChIKeyGNHURNOJCFUKEU-HGXDOMRPSA-N
MW2857.53 g/mol
LogP32.10
Rot. Bonds58

About (2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide

(2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide (PubChem CID 167575913) has the molecular formula C170H184F6N30O6 and a molecular weight of 2857.53 g/mol. Its IUPAC name is (2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide.

Molecular Properties

Compound Name(2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide
PubChem CID167575913
Molecular FormulaC170H184F6N30O6
Molecular Weight2857.53 g/mol
Exact Mass2855.49
IUPAC Name(2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide
SMILESCCCCCCc1ccc([C@@H](NCCc2ccc(C)cc2)C(=O)Nc2ccc(-c3cnn(C)c3)cn2)cc1.CCCCCCc1ccc([C@H](NCCc2ccc(C)cc2)C(=O)Nc2ccc(-c3cnn(C)c3)cn2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2cc(-c3cnn(C)c3)ccn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccc(C(F)(F)F)cc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2cc(-c3cnn(C)c3)ccn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccc(C(F)(F)F)cc2)cc1
InChIInChI=1S/2C32H39N5O.2C27H26F3N5O.2C26H27N5O/c2*1-4-5-6-7-8-25-13-15-27(16-14-25)31(33-20-19-26-11-9-24(2)10-12-26)32(38)36-30-18-17-28(21-34-30)29-22-35-37(3)23-29;2*1-18-3-5-19(6-4-18)13-14-31-25(20-7-10-23(11-8-20)27(28,29)30)26(36)34-24-12-9-21(15-32-24)22-16-33-35(2)17-22;2*1-19-8-10-20(11-9-19)12-14-28-25(21-6-4-3-5-7-21)26(32)30-24-16-22(13-15-27-24)23-17-29-31(2)18-23/h2*9-18,21-23,31,33H,4-8,19-20H2,1-3H3,(H,34,36,38);2*3-12,15-17,25,31H,13-14H2,1-2H3,(H,32,34,36);2*3-11,13,15-18,25,28H,12,14H2,1-2H3,(H,27,30,32)/t2*31-;4*25-/m101010/s1
InChIKeyGNHURNOJCFUKEU-HGXDOMRPSA-N
XLogP32.10
TPSA431.04 Ų
H-Bond Donors12
H-Bond Acceptors30
Rotatable Bonds58
Heavy Atoms212
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002857.53
LogP ≤ 532.10
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide?
The IUPAC name of (2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide (CID 167575913) is (2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide.
What is the SMILES notation for (2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide?
The canonical SMILES for (2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide is CCCCCCc1ccc([C@@H](NCCc2ccc(C)cc2)C(=O)Nc2ccc(-c3cnn(C)c3)cn2)cc1.CCCCCCc1ccc([C@H](NCCc2ccc(C)cc2)C(=O)Nc2ccc(-c3cnn(C)c3)cn2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2cc(-c3cnn(C)c3)ccn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccc(C(F)(F)F)cc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2cc(-c3cnn(C)c3)ccn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccc(C(F)(F)F)cc2)cc1.
What is the InChIKey of (2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide?
The InChIKey is GNHURNOJCFUKEU-HGXDOMRPSA-N. The full InChI is InChI=1S/2C32H39N5O.2C27H26F3N5O.2C26H27N5O/c2*1-4-5-6-7-8-25-13-15-27(16-14-25)31(33-20-19-26-11-9-24(2)10-12-26)32(38)36-30-18-17-28(21-34-30)29-22-35-37(3)23-29;2*1-18-3-5-19(6-4-18)13-14-31-25(20-7-10-23(11-8-20)27(28,29)30)26(36)34-24-12-9-21(15-32-24)22-16-33-35(2)17-22;2*1-19-8-10-20(11-9-19)12-14-28-25(21-6-4-3-5-7-21)26(32)30-24-16-22(13-15-27-24)23-17-29-31(2)18-23/h2*9-18,21-23,31,33H,4-8,19-20H2,1-3H3,(H,34,36,38);2*3-12,15-17,25,31H,13-14H2,1-2H3,(H,32,34,36);2*3-11,13,15-18,25,28H,12,14H2,1-2H3,(H,27,30,32)/t2*31-;4*25-/m101010/s1.
What are the key properties of (2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide?
(2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide has a molecular weight of 2857.53 g/mol, XLogP of 32.10, 58 rotatable bonds, 12 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(4-hexylphenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[4-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[4-(trifluoromethyl)phenyl]acetamide is sourced from PubChem (CID 167575913), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).